The Discounted Cash Flow (DCF) valuation of Rigel Pharmaceuticals Inc (RIGL) is 32.79 USD. With the latest stock price at 21.91 USD, the upside of Rigel Pharmaceuticals Inc based on DCF is 49.6%.
Based on the latest price of 21.91 USD and our DCF valuation, Rigel Pharmaceuticals Inc (RIGL) is a buy. buying RIGL stocks now will result in a potential gain of 49.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 10.3% | 8.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 21.11 - 76.17 | 32.79 |
| Upside | -3.6% - 247.7% | 49.6% |